Patients with DMD prescribed appropriate disease modifying pharmaceutical therapy

Measure Purpose: Preservation of ambulation and the minimization of later respiratory, cardiac, and orthopedic complications.

The numerator: Patients prescribed appropriate DMD disease-modifying pharmaceutical therapy*

*See full specifications for additional details

is divided by

The denominator: All patients diagnosed with Duchenne muscular dystrophy (DMD)

Exclusions are removed from the denominator for: 

• Medical contraindication
• Patient already on corticosteroid
• May not be medically appropriate depending upon functional capability, age, and existing risk factors
• Patient or caregiver decline
• Patient has no insurance to cover prescription and cannot afford it

Key Phrases

Key Phrases you should use to meet this measure include:

• Prescribed disease-modifying therapy
• Prescribed corticosteroids

Measure Calculation Example

Dr. Green had 20 patients with Duchenne muscular dystrophy between January 1 and December 31 of the measurement year. This is the denominator. One patient has a contraindication for disease-modifying therapy and one patient is already on a corticosteroid. These patients are removed from the denominator.

Of the remaining 18 patients, 13 were prescribed disease-modifying therapy. This is the numerator.

Quality of care = 13/(20-2). Dr. Green has a score of 72% for this measure.